Press Release: hC Bioscience : hC Bioscience's Preclinical Study Shows Promise for tRNA-Based Cancer Therapy

Boston, Massachusetts--(Newsfile Corp. - June 7, 2023) - hC Bioscience announced its tRNA-based therapy demonstrated proof-of-concept in an in vivo model of metastatic colorectal cancer with 75% tumor growth inhibition. This is the first report...